Clinical Trials Browser

OTHER_GOV × Pemetrexed × Clear all

NCT07050043 2025-07-03

LEDANG

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06643000 2025-03-06

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT05805631 2024-05-01

Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06208033 2024-01-17

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Phase EARLY_PHASE1 Unknown

EGFR Positive Non-small Cell Lung Cancer

NCT02737774 2020-07-01

Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation

Phase 2 Unknown

Adenocarcinoma of Lung

NCT03790228 2020-04-15

Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC

Phase 1 Unknown

Non-squamous Cell Non-Small Cell Lung Cancer

NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma of Lung

NCT01356368 2014-01-22

Customizing

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01836575 2013-04-22

PS2

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

NCT01442909 2011-09-29

Pemetrexed Followed by Docetaxel or in Reverse Sequence

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms